Posts Tagged ‘Biovail Corp.’
Biovail Settles with SEC. Three Executives Still under Investigation.
Written by Sadaka Associates
Monday, 24 March 2008 16:27
The U.S. Securities and Exchange Commission said on Monday that Canada‘s Biovail Corp. will pay $10 million to settle fines stemming from a probe into fraudulent accounting.
The SEC said current and former senior Biovail executives were obsessed with meeting quarterly and annual targets, and they overstated earnings and hid losses to deceive investors.
The SEC complaint alleges that in October 2003, Biovail and some of its executives schemed to deceive investors by falsely attributing nearly half of Biovail’s failure to meet its third quarter forecast to a single truck accident.
The complaint also alleges that over several reporting periods in 2001 and 2002, Biovail improperly moved about $47 million in research and development expenses off its financial statements and on to the financial statements of a special purpose entity.
The SEC also claimed that Biovail intentionally misstated foreign exchange losses that caused its 2003 second quarter loss to be understated by about $3.9 million.
Despite the settlement, the drugmaker’s founder, Eugene Melnyk, and three other current and former executives still face charges.
In addition, Canada‘s major securities regulator, the Ontario Securities Commission, said it has scheduled a hearing for April 22 on issues concerning Biovail.
Biovail faces U.S. grand jury probe on Cardizem
Written by Sadaka Associates
Monday, 04 February 2008 13:03
Biovail Corp said on Friday it is being investigated by a U.S. federal grand jury in Boston in connection with the 2003 commercial launch of its Cardizem LA heart drug, and analysts speculated the probe might delve into whether physicians were paid to prescribe the treatment. The company would not elaborate on the exact nature of the investigation, and officials in Boston would not comment.
“We’re not confirming or denying a grand jury investigation,” said Christina Diiorio-Sterling, a spokeswoman at the United States Attorney’s Office, District of Massachusetts.
Learn More: Reuters
Contact Us | Vaginal Mesh Injury | Help for Gardasil Injury
Copying text from this site is prohibited by copyright law.
Please note that you are not considered a client until
you have signed a retainer agreement and your case has been accepted by us. Prior
results do not guarantee or predict a similar outcome with respect to any future matter.
ATTORNEY ADVERTISING
Law Offices of Sadaka Associates represents drug injury clients in drug injury lawsuits nationwide, including Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin and Wyoming.
We also serve the cities of New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose City, Detroit, Jacksonville, Indianapolis, San Francisco, Columbus, Austin, Memphis, Fort Worth, Baltimore, Charlotte, Boston, Seattle, Washington, Milwaukee, Denver, Louisville, Las Vegas, Nashville, Oklahoma City, Portland, Tucson, Albuquerque, Atlanta, Long Beach, Fresno, Sacramento, Mesa, Kansas City, Cleveland, Virginia Beach, Omaha, Miami, Oakland, Tulsa, Honolulu, Minneapolis, Colorado Springs, Arlington and Wichita.
__________________________________
Law Offices of Sadaka Associates LLC
20 North Van Brunt Street
Englewood, NJ 07631
Phone: 201-266-5670 Fax: 201-266-5671
